Zosano Pharma Corporation ZSAN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Zosano Pharma Corporation (ZSAN), 포함 38 건 매수 및 11 건 매도. 내부자 매수 총액은 $5.29M 내부자 매도 총액은 $38.93K.

최근 활동이 있는 주요 내부자에는 Lo Steven, Matthews Christine, Kellerman Donald J. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — ZSAN

날짜	이름	직책	거래 유형	주식수	평균 가격	금액	보유 주식수
2022-06-06	Lo Steven	Chief Executive Officer	정보 매도	442	$0.71	$313.82	13,163
2022-06-06	Matthews Christine	Chief Financial Officer	정보 매도	82	$0.71	$58.22	4,183
2022-03-31	Kellerman Donald J	VP, Clinical Dev & Med Affairs	정보 매도	4,006	$0.21	$841.66	56,331
2022-03-31	Lo Steven	Chief Executive Officer	정보 매도	23,633	$0.21	$4.97K	460,709
2022-03-31	Matthews Christine	Chief Financial Officer	정보 매도	8,116	$0.21	$1.71K	146,425
2021-11-23	Greathouse Kenneth	Director	정보 매도	10,000	$0.60	$6.02K	43,500
2021-10-15	Kellerman Donald J	VP, Clinical Dev & Med Affairs	RSU 부여	20,000	$0.63	$12.68K	20,000
2021-10-15	Lo Steven	Chief Executive Officer	RSU 부여	237,500	$0.63	$150.62K	237,500
2021-10-15	Matthews Christine	Chief Financial Officer	RSU 부여	112,500	$0.63	$71.35K	112,500
2021-06-10	Greathouse Kenneth	Director	RSU 부여	30,000	$0.93	$27.95K	30,000
2021-06-10	Elms Steve	Director	RSU 부여	15,000	-	-	22,500
2021-06-10	Xanthopoulos Kleanthis G	Director	RSU 부여	15,000	-	-	23,596
2021-06-10	Hagan Joseph P	Director	RSU 부여	15,000	-	-	22,500
2021-06-04	Kellerman Donald J	VP, Clinical Dev & Med Affairs	정보 매도	1,709	$0.81	$1.38K	50,337
2021-06-04	Lo Steven	Chief Executive Officer	정보 매도	13,158	$0.81	$10.59K	365,592
2021-06-04	Lewis Hayley	See Remarks	정보 매도	1,709	$0.81	$1.38K	49,779
2021-06-04	Matthews Christine	Chief Financial Officer	정보 매도	1,709	$0.81	$1.38K	98,291
2021-05-17	Greathouse Kenneth	Director	RSU 부여	21,000	$0.73	$15.31K	38,500
2021-03-30	Kellerman Donald J	VP, Clinical Dev & Med Affairs	RSU 부여	32,500	-	-	52,046
2021-03-30	Lo Steven	Chief Executive Officer	RSU 부여	232,500	-	-	378,750
2021-03-30	Lewis Hayley	See Remarks	RSU 부여	32,500	-	-	51,488
2021-03-30	Matthews Christine	Chief Financial Officer	RSU 부여	81,250	-	-	100,000
2021-03-18	Lo Steven	Chief Executive Officer	RSU 부여	450,000	$1.37	$616.5K	450,000
2020-06-25	Kellerman Donald J	VP, Clinical Dev & Med Affairs	RSU 부여	18,750	-	-	19,546
2020-06-25	Greathouse Kenneth	Director	RSU 부여	7,500	-	-	17,500
2020-06-25	Walker John Peter	Director	RSU 부여	7,500	-	-	116,511
2020-06-25	Elms Steve	Director	RSU 부여	7,500	-	-	7,500
2020-06-25	Xanthopoulos Kleanthis G	Director	RSU 부여	7,500	-	-	8,596
2020-06-25	Hagan Joseph P	Director	RSU 부여	7,500	-	-	7,500
2020-06-25	Lo Steven	Chief Executive Officer	RSU 부여	146,250	-	-	146,250
2020-06-25	Lewis Hayley	See Remarks	RSU 부여	18,750	-	-	18,988
2020-06-25	Matthews Christine	Chief Financial Officer	RSU 부여	18,750	-	-	18,750
2020-06-03	Kellerman Donald J	VP, Clinical Dev & Med Affairs	RSU 부여	37,500	$1.01	$37.88K	37,500
2020-06-03	Greathouse Kenneth	Director	RSU 부여	15,000	$1.01	$15.15K	15,000
2020-06-03	Walker John Peter	Director	RSU 부여	15,000	$1.01	$15.15K	15,000
2020-06-03	Elms Steve	Director	RSU 부여	15,000	$1.01	$15.15K	15,000
2020-06-03	Xanthopoulos Kleanthis G	Director	RSU 부여	15,000	$1.01	$15.15K	15,000
2020-06-03	Hagan Joseph P	Director	RSU 부여	15,000	$1.01	$15.15K	15,000
2020-06-03	Lo Steven	Chief Executive Officer	RSU 부여	292,500	$1.01	$295.43K	292,500
2020-06-03	Lewis Hayley	See Remarks	RSU 부여	37,500	$1.01	$37.88K	37,500
2020-06-03	Matthews Christine	Chief Financial Officer	RSU 부여	37,500	$1.01	$37.88K	37,500
2020-05-01	Matthews Christine	Chief Financial Officer	RSU 부여	35,000	$0.70	$24.54K	35,000
2020-02-03	Matthews Christine	See Remarks	처분	3,750	$2.75	$10.31K	-
2019-12-02	Aisling Capital Iv, Lp	10 Percent Owner	RSU 부여	689,655	$1.45	$1000K	2,718,226
2019-10-21	Lo Steven	Chief Executive Officer	알 수 없음	-	-	-	-
2019-10-21	Lo Steven	Chief Executive Officer	RSU 부여	450,000	$1.94	$873K	450,000
2019-06-11	Kellerman Donald J	VP, Clinical Dev & Med Affairs	RSU 부여	30,000	$2.75	$82.5K	30,000
2019-06-11	Lewis Hayley	See Remarks	RSU 부여	30,000	$2.75	$82.5K	30,000
2019-04-11	Aisling Capital Iv, Lp	10 Percent Owner	RSU 부여	428,571	$3.50	$1.5M	2,028,571
2019-04-11	Walker John Peter	President & CEO	정보 매수	100,000	$3.50	$350K	280,228